Rihim Pharma Consultancy Private Limited

Provides pharma consultancy services for various clients since 2010.

2010 | Delhi (India) | Active
Last Updated: October 24, 2024

Rihim Pharma Consultancy Profile

Key Indicators

  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.54 Cr
  • Satisfied Charges ₹ 1.02 Cr
  • Revenue Growth 24.16%
  • Profit Growth 10.80%
  • Ebitda -34.84%
  • Net Worth 30.71%
  • Total Assets 19.07%

About Rihim Pharma Consultancy

Rihim Pharma Consultancy Private Limited (RPCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 May 2010 and has a history of 14 years and nine months. Its registered office is in Delhi, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹1.54 Cr. The company has closed loans amounting to ₹1.02 Cr, as per Ministry of Corporate Affairs (MCA) records.

Gautam Kamdar, Nilesh Thosani, and Ratna Thosani serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    rihimpharma.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U52100DL2010PTC202258

  • Company No.

    202258

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 May 2010

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Healthcare

What products or services does Rihim Pharma Consultancy Private Limited offer?

Rihim Pharma Consultancy Private Limited offers a wide range of products and services, including Company Law & Labour Law Consultants, Statutory Compliance Services, Legal Drafting & Litigation Services, Affidavit Attestation Service, Medical Consultants & Clinics, Medical Consultancy Services.

Who are the key members and board of directors at Rihim Pharma Consultancy?

Board Members (3)

NameDesignationAppointment DateStatus
Gautam Kamdar Country flag representing In Director 04-May-2010Current
Nilesh Thosani Country flag representing In Director 04-May-2010Current
Ratna Thosani Country flag representing In Director 04-May-2010Current

Financial Performance of Rihim Pharma Consultancy.

Rihim Pharma Consultancy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.16% increase. The company also saw a substantial improvement in profitability, with a 10.8% increase in profit. The company's net worth Soared by an impressive increase of 30.71%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
24.16%
Revenue from Operations
25.05%
Total Assets
19.07%
Profit or Loss
10.80%
Net Worth
30.71%
EBITDA
-34.84%

What is the Ownership and Shareholding Structure of Rihim Pharma Consultancy?

In 2023, Rihim Pharma Consultancy had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹15.39 M

Satisfied Charges

₹10.24 M

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 0.80 Cr
  • Others : 0.56 Cr
  • Hdfc Bank Limited : 0.19 Cr

Latest Charge Details

DateLenderAmountStatus
15 Sep 2023Others₹4.70 MOpen
29 Jun 2021Axis Bank Limited₹7.99 MOpen
21 Sep 2019Others₹0.85 MOpen
17 Nov 2018Hdfc Bank Limited₹1.85 MOpen
26 Sep 2018Others₹4.74 MSatisfied

How Many Employees Work at Rihim Pharma Consultancy?

Rihim Pharma Consultancy has a workforce of 7 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rihim Pharma Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rihim Pharma Consultancy's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rihim Pharma Consultancy

Recent activity within the organization

  • Charges

    A charge registered on 21 May 2018 via Charge ID 100193207 with Hdfc Bank Limited was fully satisfied on 11 Oct 2023.

    11 Oct 2023

  • Annual General Meeting

    Rihim Pharma Consultancy Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Charges

    A charge with Others amounted to Rs. 4.70 M with Charge ID 100791012 was registered on 15 Sep 2023.

    15 Sep 2023

  • Balance Sheet

    Rihim Pharma Consultancy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

    31 Mar 2023

  • Charges

    A charge registered on 26 Sep 2018 via Charge ID 100210403 with Others was fully satisfied on 14 Apr 2022.

    14 Apr 2022

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 7.99 M with Charge ID 100476905 was registered on 29 Jun 2021.

    29 Jun 2021

Frequently asked questions

  • Rihim Pharma Consultancy Private Limited was incorporated on 04 May 2010.

  • The authorized share capital of Rihim Pharma Consultancy Private Limited is ₹ 0.20 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Rihim Pharma Consultancy Private Limited.

    • Gautam Hasmukhrai Kamdar
    • Nilesh Thosani
    • Ratna Thosani
  • As per Ministry of Corporate Affairs (Mca), the registered address of Rihim Pharma Consultancy Private Limited is 518-519 Fifth Floor Ring Road Mall Manglam Place Sec-03, India, Delhi, 110085.

  • The corporate identification number (CIN) of Rihim Pharma Consultancy Private Limited is U52100DL2010PTC202258 and the company number is 202258 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Rihim Pharma Consultancy Private Limited is https://www.rihimpharma.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Rihim Pharma Consultancy Private Limited has risen by 24.16%.

  • As Per 2023 financial reports, 7 employees are currently employed by Rihim Pharma Consultancy Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Rihim Pharma Consultancy Private Limited has experienced an upsurge of 30.71%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Rihim Pharma Consultancy Private Limited amount to ₹ 1.54 Cr.

  • The most recent Balance Sheet for Rihim Pharma Consultancy Private Limited was filed with the ROC on 31 Mar 2023.